Clinical Trial Update: Duvelisib Maintenance for the Treatment of Peripheral T-Cell Lymphomas [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating duvelisib as maintenance therapy for peripheral T-cell lymphomas, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Helper T-cell Lymphoma
• Peripheral T-cell Lymphoma Not Otherwise Specified

Drugs mentioned

• COPIKTRA (duvelisib)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Follicular Helper T-Cell Lymphoma, Peripheral T-Cell Lymphoma, Not Otherwise Specified | Phase 2 | Status: NOT_YET_RECRUITING